NCT03109990View on ClinicalTrials.gov

A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery

NACompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Breast Cancer
Interventions
DRUG

Dexmedetomidine

Patients in the experimental group will receive Dexmedetomidine during surgery.

DRUG

Saline

Patients in the control group will receive saline but not Dexmedetomidine during surgery.

Trial Locations (1)

200127

Renji hospital, School of Medicine, Shanghai Jiaotong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT03109990 - A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery | Biotech Hunter | Biotech Hunter